THE HAGUE, The Netherlands, June 30, 2025 (GLOBE NEWSWIRE) -- In a strategic move to improve patient outcomes in breast cancer, Affidea, a leading pan-European provider of community-based polyclinics, ...
As part of this partnership, Affidea has implemented Skin Analytics’ DERM, an AI medical device software for the automated analysis of skin lesions. The initial implementation of DERM began in Romania ...
THE HAGUE, Netherlands, March 4, 2024 /PRNewswire/ -- Affidea Group, Europe's largest provider of advanced diagnostics, multi-speciality polyclinics and Centres of Excellence, announced today that it ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
DUBLIN-headquartered Affidea, a leading provider of advanced diagnostics, out-of-hospital services, and centres of excellence in cancer care and orthopaedics, plans to open a new medical facility in ...
THE HAGUE, Netherlands, Feb. 27, 2024 /PRNewswire/ -- Affidea, Europe's largest community-based outpatient services provider with a core in diagnostic imaging that has grown to offer a broad service ...
THE HAGUE, The Netherlands, June 30, 2025, a leading pan-European provider of community-based polyclinics, specialist services and advanced diagnostics, is proud to announce that it has selected ...
THE HAGUE, The Netherlands, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Affidea, a leading pan-European provider of community-based polyclinics, advanced diagnostics, and multi-specialist care, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results